The U.K. has made progress in an estimated $624 million deal to buy a COVID-19 vaccine from Sanofi and GlaxoSmithKline and deliver 60 million doses to its citizens.Original Article
UK Now Close To Get Supply Deal For Another Coronavirus Vaccine
You may also like
Ninth Circuit Upholds FDA’s Authority to Regulate...
Skinny-Label Lives to See Another Day
Bring Out Your Meds! Bring Out Your Meds!
Homeopathic Industry Group Wants Court to Exclude It...
A Reversal on Sequencing? Proposed Legislation Would...
FDA Guidance Outlines a Framework for the Evaluation...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.